B of A Securities Initiates Coverage of Sutro Biopharma (STRO) with Buy Recommendation
Fintel reports that on May 8, 2024, B of A Securities initiated coverage of Sutro Biopharma (NasdaqGM:STRO) with a Buy recommendation. Analyst Price Forecast Suggests 209.33% Upside As of May 2, 2024, the average one-year price target for Sutro Biopharma...
Fintel